Aims and scope

Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international subscription-based journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature.

The Editors welcome:

• Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area
• Patent Evaluations examining the aims and chemical and biological claims of individual patents
• Perspectives on issues relating to intellectual property

The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.

Article Highlights - an executive summary of the author's most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Therapeutic Patents, part of the Expert Collection brand. 

Authors can publish gold open access in this journal and may choose to publish using our Accelerated Publication services.

Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.